Universal Ibogaine CEO Nick Karos joins Natalie Stoberman in the Proactive Studio about the company's newly formed external advisory board. Karos says the board is part of the company's strategic plans and mission to deliver medicalized ibogaine-centred addiction care, as the company undertakes a planned clinical trial application process. The advisory board is intended to allow the company to draw on a broad range of expertise and experience of its members from various fields, including medical practice, First Nations leadership, psychedelics research, government relations and grant funding.
Universal Ibogaine announces formation of advisory board
